WallStreetZenWallStreetZen

NASDAQ: WVE
Wave Life Sciences Ltd Stock Forecast, Predictions & Price Target

Analyst price target for WVE

Based on 1 analyst offering 12 month price targets for Wave Life Sciences Ltd.
Min Forecast
$12.00+136.69%
Avg Forecast
$12.00+136.69%
Max Forecast
$12.00+136.69%

Should I buy or sell WVE stock?

Based on 1 analyst offering ratings for Wave Life Sciences Ltd.
Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their WVE stock forecasts and price targets.

WVE stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2023-12-19

1 of 1

Forecast return on equity

Is WVE forecast to generate an efficient return?
Insufficient data to display

Forecast return on assets

Is WVE forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

WVE revenue forecast

What is WVE's revenue in the next 3 years based on estimates from 3 analysts?
Avg 1 year Forecast
$80.8M-5.48%
Avg 2 year Forecast
$35.7M-58.3%
Avg 3 year Forecast
$85.0M-0.57%
WVE's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

WVE revenue growth forecast

How is WVE forecast to perform vs Biotechnology companies and vs the US market?
Company
-0.19%
Industry
45.3%
Market
10.84%
WVE's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
WVE's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

WVE vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
WVE$5.07$12.00+136.69%Buy
LRMR$11.42$17.50+53.24%Strong Buy
CDMO$7.99$12.33+54.36%Strong Buy
MREO$3.86$4.50+16.58%Strong Buy
AEON$13.72N/AN/A

Wave Life Sciences Stock Forecast FAQ

Is Wave Life Sciences Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: WVE) stock is to Buy WVE stock.

Out of 1 analyst, 0 (0%) are recommending WVE as a Strong Buy, 1 (100%) are recommending WVE as a Buy, 0 (0%) are recommending WVE as a Hold, 0 (0%) are recommending WVE as a Sell, and 0 (0%) are recommending WVE as a Strong Sell.

If you're new to stock investing, here's how to buy Wave Life Sciences stock.

What is WVE's revenue growth forecast for 2024-2026?

(NASDAQ: WVE) Wave Life Sciences's forecast annual revenue growth rate of -0.19% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 45.3%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.84%.

Wave Life Sciences's revenue in 2024 is $85,488,000.On average, 3 Wall Street analysts forecast WVE's revenue for 2024 to be $8,003,654,336, with the lowest WVE revenue forecast at $6,181,260,647, and the highest WVE revenue forecast at $9,905,390,200. On average, 3 Wall Street analysts forecast WVE's revenue for 2025 to be $3,531,469,714, with the lowest WVE revenue forecast at $3,070,670,962, and the highest WVE revenue forecast at $4,273,185,332.

In 2026, WVE is forecast to generate $8,419,878,832 in revenue, with the lowest revenue forecast at $5,082,356,658 and the highest revenue forecast at $11,589,306,534.

What is WVE's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: WVE) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is WVE's Price Target?

According to 1 Wall Street analyst that have issued a 1 year WVE price target, the average WVE price target is $12.00, with the highest WVE stock price forecast at $12.00 and the lowest WVE stock price forecast at $12.00.

The Wall Street analyst predicted that Wave Life Sciences's share price could reach $12.00 by Dec 19, 2024. The average Wave Life Sciences stock price prediction forecasts a potential upside of 136.69% from the current WVE share price of $5.07.

What is WVE's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: WVE) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.